Performant Healthcare INC

Performant Healthcare, Inc. has completed its acquisition by Continental Buyer, Inc., with shareholders receiving $7.75 per share in cash.

Performant Healthcare, Inc. stockholders have approved the Agreement and Plan of Merger with Continental Buyer, Inc., paving the way for the company to become a wholly-owned subsidiary.

Performant Healthcare, Inc. reported preliminary second-quarter 2025 financial results and announced a definitive agreement to be acquired by Machinify, leading to the withdrawal of its full-year guidance and cancellation of its earnings call.

Performant Healthcare, Inc. has entered into a definitive merger agreement to be acquired by Machinify, a New Mountain Capital portfolio company, for $7.75 per share in cash, representing a 139% premium.

Performant Healthcare, Inc. announced the results of its 2025 Annual Meeting of Stockholders, where three Class I directors were elected and the appointment of Baker Tilly US, LLP as independent auditor for 2025 was ratified.

Performant Healthcare, Inc. announced positive financial results for the first quarter of 2025, with increased revenue and adjusted EBITDA, leading to an improved outlook for the full year.

Performant Healthcare, a leading payment integrity provider, reported a significant turnaround to net income in Q2 2025 and announced its agreement to be acquired by Machinify for $7.75 per share.

Performant Healthcare's Q1 2025 shows a significant revenue increase and a substantial reduction in net loss compared to the same period last year.

Performant Financial Corporation's Q3 2024 results show a revenue increase driven by its healthcare segment, despite an overall net loss.

Performant Financial Corporation's second quarter results show revenue growth driven by healthcare services, with a reduced net loss compared to the same period last year.

Performant Financial Corporation's first quarter 2024 results show a slight improvement in net loss compared to the same period last year, with increased healthcare revenues offset by a decline in outsourced services.

Performant Healthcare, Inc. announces its financial results for the year ended December 31, 2024, highlighting an 8% increase in revenue to $123.0 million.

Performant Financial Corporation's 10-K filing outlines the details of their common stock, business operations, and financial results for the year ended December 31, 2023.

Performant Healthcare Inc. director Eric Yanagi reports the disposition of shares and restricted stock units on October 21, 2025, due to the company's acquisition by Continental Buyer, Inc. for $7.75 per share.

Performant Healthcare Inc. Director William Dean Hansen disposed of all common stock and restricted stock units as the company completed its merger with Continental Buyer, Inc. for $7.75 per share.

Performant Healthcare Director Lisa Im disposed of all her shares following the company's merger into a wholly-owned subsidiary of Continental Buyer, Inc., receiving $7.75 per share.

Performant Healthcare Inc. CEO Simeon Kohl reports the conversion of common stock and restricted stock units into cash following the company's merger with Continental Buyer, Inc.

Director James LaCamp reports the disposition of all Performant Healthcare shares and restricted stock units due to the company's merger with Continental Buyer, Inc. at $7.75 per share.

Performant Healthcare Inc. Chief Financial Officer Rohit Ramchandani converted all his equity holdings into cash following the company's merger with Continental Buyer, Inc.

Performant Healthcare issues a proxy supplement addressing shareholder lawsuits and clarifying merger valuation details for its acquisition by Machinify.

Performant Healthcare, Inc. stockholders are invited to a special meeting on October 17, 2025, to vote on a merger agreement to be acquired by Continental Buyer, Inc. for $7.75 per share in cash.

Performant Healthcare, Inc. has entered into a definitive agreement to be acquired by healthcare intelligence leader Machinify, aiming to enhance healthcare payments accuracy and transparency.

Performant Healthcare, Inc. announced an agreement to be acquired by Machinify, aiming to enhance resources and growth opportunities.

Performant Healthcare, Inc. files definitive additional materials related to its proxy statement.

Performant Healthcare announces its 2025 Annual Meeting of Stockholders to be held on June 18, 2025, to elect directors and ratify the appointment of its independent auditor.

Performant Healthcare Inc. has been acquired by Continental Buyer, Inc. for $7.75 per share, leading Prescott Group to cease beneficial ownership.

Prescott Group Capital Management, a significant shareholder in Performant Healthcare, Inc., has entered into a confidentiality and standstill agreement with the company, limiting its activist actions for 12 months while it evaluates the business.

Topline Capital Management and its affiliates have reported a 0% beneficial ownership in Performant Healthcare, Inc., indicating a full divestment of their previous stake.

Glazer Capital, LLC and Paul J. Glazer have reported beneficial ownership of 8.4% of Performant Healthcare, Inc.'s common stock.

The Vanguard Group has reported a 4.94% beneficial ownership in Performant Healthcare Inc. common stock as of September 30, 2025.

Glazer Capital and Paul J. Glazer have reported a reduction in their beneficial ownership of scPharmaceuticals Inc. common stock to 4.64%, falling below the 5% threshold.

Glazer Capital, LLC and Paul J. Glazer have reported a passive beneficial ownership of 5.82% in Performant Healthcare, Inc., totaling 4,595,936 shares of common stock.

First Light Asset Management and Mathew P. Arens have increased their beneficial ownership in Performant Healthcare, Inc., now holding 15.42% and 16.36% respectively.